Intranasal LPS-Mediated Parkinson’s Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Accumulating evidence implicates the relationship between neuroinflammation and pathogenesis in idiopathic Parkinson's disease (iPD). The nose has recently been considered a gate way to the brain which facilitates entry of environmental neurotoxin into the brain. Our study aims to build a PD model by a natural exposure route. In this report, we establish a new endotoxin-based PD model in mice by unilateral intranasal (i.n.) instillation of the lipopolysaccharides (LPS) every other day for 5 months. These mice display a progressive hypokinesia, selective loss of dopaminergic neurons, and reduction in striatal dopamine (DA) content, as well as α-synuclein aggregation in the SN, without systemic inflammatory and immune responses. This new PD model provides a tool for studying the inflammation-mediated chronic pathogenesis and searching for therapeutic intervention in glia-neuron pathway that will slow or halt neurodegeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · cited 3×
“Lipopolysaccharide (LPS), as a potent glial activator, has been used for the induction of dopamine (DA) neurodegeneration through intracranial and intraperitoneal injection [7].”
BackgroundInfluential
Research works printed but not linked: 34
- AE Lang, 1998, Parkinson's disease. First of two parts, N Engl J Med, 339, 1044
- R Betarbet, 2002, Animal models of Parkinson's disease, Bioessays, 24, 308, 10.1002/bies.10067 · DOI · Paper page
- F Blandini, 2012, Animal models of Parkinson's disease, FEBS J, 279, 1156, 10.1111/j.1742-4658.2012.08491.x · DOI · Paper page
- TM Dawson, 2010, Genetic animal models of Parkinson's disease, Neuron, 66, 646, 10.1016/j.neuron.2010.04.034 · DOI · Paper page
- CK Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
- Y Ouchi, 2009, Neuroinflammation in the living brain of Parkinson's disease, Parkinsonism Relat Disord, 15, S200, 10.1016/S1353-8020(09)70814-4 · DOI · Paper page
- BD Jung, 2010, Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration, Neurochem Int, 56, 229, 10.1016/j.neuint.2009.10.005 · DOI
- S Genc, 2012, The adverse effects of air pollution on the nervous system, J Toxicol, 2012, 10.1155/2012/782462 · DOI · Paper page
- WG Kim, 2000, Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia, J Neurosci, 20, 6309, 10.1523/JNEUROSCI.20-16-06309.2000 · DOI · Paper page
- WD Clapp, 1993, The effects of inhalation of grain dust extract and endotoxin on upper and lower airways, Chest, 104, 825, 10.1378/chest.104.3.825 · DOI
- LH Tonelli, 2010, Airborne inflammatory factors: "from the nose to the brain", Front Biosci (Schol Ed), 2, 135, 10.2741/s52 · DOI · Paper page
- H Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
- RL Doty, 2008, The olfactory vector hypothesis of neurodegenerative disease: is it viable?, Ann Neurol, 63, 7, 10.1002/ana.21327 · DOI · Paper page
- CL Graff, 2005, Nasal drug administration: potential for targeted central nervous system delivery, J Pharmacol Sci, 94, 1187, 10.1002/jps.20318 · DOI · Paper page
- V Bouet, 2009, The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice, Nat Protoc, 4, 1560, 10.1038/nprot.2009.125 · DOI · Paper page
- YQ Wang, 2012, Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats, J Neurochem, 120, 314, 10.1111/j.1471-4159.2011.07558.x · DOI
- ZY Hong, 2005, Orexin A promotes histamine, but not norepinephrine or serotonin, release in frontal cortex of mice, Acta Pharmacol Sin, 26, 155, 10.1111/j.1745-7254.2005.00523.x · DOI
- MG Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
- JP Moore, 2013, A flow cytometric method for the analysis of macrophages in the vascular wall, J Immunol Methods
- S Krueger, 2013, Induction of premalignant host responses by cathepsin x/z-deficiency in helicobacter pylori-infected mice, PLOS ONE, 8, e70242, 10.1371/journal.pone.0070242 · doi:10.1371/journal.pone.0070242
- S Izuta, 2012, T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice, Biotechnol Lett, 34, 2175, 10.1007/s10529-012-1022-4 · DOI
- NF Kurniati, 2012, Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury, Nephrol Dial Transplant
- KL Lim, 2009, Genetic models of Parkinson disease, Biochim Biophys Acta, 1792, 604, 10.1016/j.bbadis.2008.10.005 · DOI
- B Liu, 2002, Role of nitric oxide in inflammation-mediated neurodegeneration, Ann N Y Acad Sci, 962, 318, 10.1111/j.1749-6632.2002.tb04077.x · DOI · Paper page
- MB Stern, 1994, Olfactory function in Parkinson's disease subtypes, Neurology, 44, 266, 10.1212/WNL.44.2.266 · DOI · Paper page
- JH Friedman, 2008, Rhinorrhea and olfaction in Parkinson disease, Neurology, 70, 487, 10.1212/01.wnl.0000279380.25130.ce · doi:10.1212/01.wnl.0000279380.25130.ce
- C Delayre-Orthez, 2005, Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma, Int Arch Allergy Immunol, 138, 298, 10.1159/000088867 · DOI
- S Sultan, 2011, Acquisition of an olfactory associative task triggers a regionalized down-regulation of adult born neuron cell death, Front Neurosci, 5, 52, 10.3389/fnins.2011.00052 · DOI
- S Funabe, 2012, Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa, Neuropathology
- A Pignatelli, 2013, The h-current in periglomerular dopaminergic neurons of the mouse olfactory bulb, PLOS ONE, 8, e56571, 10.1371/journal.pone.0056571 · DOI
- ML Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, 57, 10.1038/nrn2038 · DOI · Paper page
- P Damier, 1999, The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease, Brain, 122, 1437, 10.1093/brain/122.8.1437 · DOI · Paper page
- G Lunardi, 2009, Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease, Parkinsonism Relat Disord, 15, 383, 10.1016/j.parkreldis.2008.10.001 · doi:10.1016/j.parkreldis.2008.10.001
- I Pérez-Otaño, 1994, MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration, Neurosci Lett, 175, 121, 10.1016/0304-3940(94)91094-4 · DOI
Cited by
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
“, 2013), inflammation can in return promote the aggregation of some prion-like proteins in the brain and peripheral cells (Correia et al., 2015; He et al., 2013; Kitazawa et al., 2005; Lee et al., 2008; Sy et al., 2011; Vieira et al., 2015).”
Gorecki, A. M., Preskey, L., Bakeberg, M. C., Kenna, J. E., Gildenhuys, C., MacDougall, G., Dunlop, S. A., Mastaglia, F. L., Akkari, P. A., Koengten, F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00839 · Cited by 184
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
Kim, C., Lv, G., Lee, J. S., Jung, B. C., Masuda-Suzukake, M., Hong, C.-S., Valera, E., Lee, H.-J., Paik, S. R., Hasegawa, M., et al. (2016) · Scientific Reports · doi:10.1038/srep30891 · Cited by 138
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124
“Nigrostriatal neurodegeneration can be evoked by stereotaxic injection or systemic application of lipopolysaccharide (LPS), a known activator of microglia (Frank-Cannon et al. 2008; He et al. 2013; Herrera et al. 2000; Ramsey and Tansey 2014).”
BackgroundHe, Q., Li, Y., Guo, S., Wang, Y., Lin, W., Zhang, Q., Wang, J., Ma, C., & Xiao, B. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13132 · Cited by 48
Self-citationRetracted
Metadata
- Authors
- He, Q., Yu, W., Wu, J., Chen, C., Lou, Z., Zhang, Q., Zhao, J., Wang, J., & Xiao, B.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-08
- Volume
- 8
- Issue
- 11
- Pages
- e78418
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2045090389
- Cited by
- 72
- References
- 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal LPS-Mediated Parkinson’s Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins. https://app.cochat.ai/papers/10.1371/journal.pone.0078418
- The paper
- He, Q., Yu, W., Wu, J., Chen, C., Lou, Z., Zhang, Q., Zhao, J., Wang, J., & Xiao, B. (2013). Intranasal LPS-Mediated Parkinson’s Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins. PLoS ONE. https://doi.org/10.1371/journal.pone.0078418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.